Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy

H Beltran, L Fazli, CC Collins, JA Eastham, MJ Morris, ME Taplin, A Sboner, S Halabi, ME Gleave, AW Wyatt, E Chedgy, A Donoghue, M Annala, E Warner, K Beja, M Sigouros, F Mo

    Research output: Contribution to journalArticleScientificpeer-review

    65 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)6802-6811
    JournalClinical Cancer Research
    Volume23
    Issue number22
    DOIs
    Publication statusPublished - 2017
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 2

    Cite this